KPV Research Evidence
The KPV evidence base: trials, journals, and what the data does not yet show.
Preclinical Evidence Only
KPV's anti-inflammatory and gut-protective effects have been studied primarily in animal colitis models and cell-based assays. No published human clinical trial exists. Its popularity as a research/self-experimentation compound has outpaced the formal evidence base considerably.
Regulatory and Legal Status
KPV has no FDA-approved indication and is not approved for human consumption. It is sold exclusively as a research-grade compound (RUO — research use only). Researchers and users should verify the legal status of KPV in their jurisdiction prior to purchase or use — regulations on unapproved peptide research chemicals vary widely and change frequently.
References
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation · Dalmasso G, et al. · 2008